Navigation Links

Biology Technology

Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com

7/31/2014
Dallas, Texas (PRWEB) August 01, 2014 “2014 Deep Research Report on Global and China Polyurethane Resin Industry” is a professional and in-depth research report on Polyurethane Resin market. The report introduces Polyurethane Resin basic information, including its definition, classification, application, and industry chain structure and industry overview. This research covers the internatio... [Comments]

Midwest Biotech Leaders Featured On BioSpace Map

7/31/2014
DENVER , July 31, 2014 Today BioSpace , the leading life sciences employment and news website, launched the 2014-2015 BioMidwest Hotbed map campaign spotlighting the life sciences community in Illinois , Indiana , Iowa , Kansas , Michigan , Minnesota , Missouri , Nebraska , Ohio and Wisconsin . BioMidwest is a leader in biotech and pharmaceu... [Comments]

Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo

7/31/2014
CHICAGO , July 31, 2014 Nearly 20,000 medical professionals and healthcare leaders gathered for AACC's 65 th Annual Meeting & Clinical Lab Expo in Chicago from July 27–31. The meeting featured never-before-seen breakthroughs in diagnostic research and technology that will advance medicine and get patients the treatment they need. As of Wednesday, Ju... [Comments]

Key to aging immune system is discovered

7/31/2014
There's a good reason people over 60 are not donor candidates for bone marrow transplantation. The immune system ages and weakens with time, making the elderly prone to life-threatening infection and other maladies, and a UC San Francisco research team now has discovered a reason why. "We ha... [Comments]Key to aging immune system is discovered

A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers

7/31/2014
Alan Turing, the British mathematician (1912-1954), is famous for a number of breakthroughs, which altered the course of the 20th century. In 1936 he published a paper, which laid the foundation of computer science, providing the first formal concept of a computer algorithm. He next played a piv... [Comments]A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers

See-through organs and bodies will accelerate biomedical discoveries

7/31/2014
The ability to see through organs and even the entire body to visualize long-range connections between cells as well as fine-grained cellular structures has been a long-time dream of biologists. A study published by Cell Press July 31st in the journal Cell has now made that dream a reality,... [Comments]See-through organs and bodies will accelerate biomedical discoveries

New mapping approach lets scientists zoom in and out as the brain processes sound

7/31/2014
Researchers at Johns Hopkins have mapped the sound-processing part of the mouse brain in a way that keeps both the proverbial forest and the trees in view. Their imaging technique allows zooming in and out on views of brain activity within mice, and it enabled the team to watch brain cells l... [Comments]New mapping approach lets scientists zoom in and out as the brain processes sound

Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures

7/31/2014
BLOOMINGTON, Ind. -- Chemists at Indiana University Bloomington have described the self-assembly of large, symmetrical molecules in bricks-and-mortar fashion, a development with potential value for the field of organic electronic devices such as field-effect transistors and photovoltaic cell... [Comments]Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures

SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research

7/31/2014
COLORADO SPRINGS, Colo. , July 31, 2014 The SNIS Foundation recognized its first Seed Grant awardee today with $25,000 to fund a translational research project.  The first award since the Foundation's inception in 2011, the gift was presented at the Society of NeuroInterventional Surgery (SNIS) 11 th Annual Meeting in Colorado Springs, CO. Representing p... [Comments]

Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research

7/31/2014
ALBANY, New York , July 31, 2014 According to a new market report published by Transparency Market Research "Quantum Dots Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2023," the market was valued at USD 88.5 million in 2011, which is expected to reach USD 8,246.8 million by 2023, growing at a CAGR of 53.8% from 2013 to 2023. Browse th... [Comments]

Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up

7/31/2014
PORTOLA VALLEY, Calif. , July 31, 2014 Rogne Bioscience, a privately-held biotechnology company based in San Francisco Bay Area , has acquired a licence to anti-inflammatory peptides from Isis Innovation, the University of Oxford's commercialisation company. The potent anti-inflammatory activity of the peptides was discovered by Professor David Greaves at the University o... [Comments]

Medicine Technology

PCMA: Medicare Part D 2015 Premiums Remain Flat

7/31/2014
WASHINGTON , July 31, 2014  According to data released today by the Centers for Medicare & Medicaid Services, the 2015 average monthly Medicare Part D premium is expected to remain stable at $32, a figure far lower than was originally projected, the Pharmaceutical Care Management Association (PCMA) said. "The popular Part D program continues to be a bright... [Comments]

Sorrento Announces the Unexpected Death of its Chief Business Officer

7/31/2014
SAN DIEGO , July 31, 2014  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; Sorrento) today announced the death of Mr. Amar Singh , Chief Business Officer and Executive Vice President. Mr. Singh died suddenly and unexpectedly of apparent natural causes on July 30. "Sorrento is deeply saddened and shocked by the loss of our dear friend and colleague. Our immediate thoughts... [Comments]

STAAR Surgical Reports 10% Second Quarter Revenue Growth

7/31/2014
MONROVIA, Calif., July 31, 2014 STAAR Surgical Company (NASDAQ: STAA ) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye today reported revenue for the second quarter ended July 4, 2014 of $20.0 million, a 10% increase over $18.2 million reported for the second quarter of 2013. On a constant currency basis, revenues grew 11% d... [Comments]

IRIDEX Reports 2014 Second Quarter, Six-Month Results

7/31/2014
MOUNTAIN VIEW, Calif., July 31, 2014 IRIDEX Corporation (Nasdaq: IRIX ) today reported financial results for the second quarter and six months ended June 28, 2014.  Revenues were $10.6 million in the second quarter of 2014, up 15% from $9.2 million in the 2013 second quarter and up sequentially from $10.3 million in the first quarter of 2014. Revenues for the first six... [Comments]

RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014

7/31/2014
SAN DIEGO, July 31, 2014  ResMed Inc. (NYSE: RMD ) today announced results for its fourth quarter and for the fiscal year ended June 30, 2014.  Revenue for the quarter was $415.2 million, flat compared to the quarter ended June 30, 2013 (a 1 percent decrease on a constant currency basis). Net income was $87.7 million, an increase of 20 percent compared to the quarter e... [Comments]

Tandem Diabetes Care Reports Second Quarter 2014 Financial Results

7/31/2014
SAN DIEGO, July 31, 2014 Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter ended June 30, 2014. In comparing the second quarter of 2014 to the same period of 2013: Sales grew 86 percent to $10.3 million from $5.5 million t:slim Pump shipments... [Comments]

Xencor Reports Second Quarter 2014 Financial Results

7/31/2014
MONROVIA, Calif., July 31, 2014 Xencor Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today reported financial results for the second quarter ended June 30, 2014 and provided a review of recent business highlights. "In the seco... [Comments]

Pharmacyclics Reports Second Quarter 2014 Results

7/31/2014
SUNNYVALE, Calif., July 31, 2014 Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today reported financial results and recent developments for the quarter ended June 30, 2014. Financial Results for the Six Months and Quarter Ended June 30, 2014 Revenue Total revenue for the quarter ended June 30, 2014 increased to $113.0 million from $54.7 million for the quarter ended Ju... [Comments]

Cepheid to Webcast Upcoming Financial Presentations

7/31/2014
SUNNYVALE, Calif. , July 31, 2014  Cepheid (NASDAQ: CPHD ) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. Wedbush Life Sciences Management Access Conference, New York, NY Wednesday, August 13, 2014 at 9.10 a.m. Eastern Time Baird Health Care Conference, New York, NY Thurs... [Comments]

Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014

7/31/2014
SAN FRANCISCO, July 31, 2014 Nektar Therapeutics (Nasdaq: NKTR ) today reported its financial results for the second quarter ended June 30, 2014. Cash and investments in marketable securities at June 30, 2014 were $301.4 million as compared to $309.1 million at March 31, 2014."The second half of 2014 will be an exciting time for Nektar as we look forward to significant miles... [Comments]

Alexza Provides Pipeline Update

7/31/2014
MOUNTAIN VIEW, Calif. , July 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today provided an update on its pipeline and new product development efforts. In the second half of 2014, Alexza expects to initiate a Phase 2a study of AZ-002 (Staccato ® alprazolam), which is being developed for the management of patients with acute repetitive seizures.  ... [Comments]

(Date:7/31/2014)... BLOOMINGTON, Ind. -- Chemists at Indiana University Bloomington ... in bricks-and-mortar fashion, a development with potential value ... as field-effect transistors and photovoltaic cells. , Their ... 3D Crystalline Solids and 2D Self-Assembled Crystals," has ... a journal of the Royal Society of Chemistry. ...
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® bearings ... are uniquely suited to prevent loss of lubrication that ... high temperatures . , Recently, a manufacturer of ... at Graphite Metallizing to overcome problems with movement of ... pans containing blocks of powder mixture are loaded onto ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 CollabRx, Inc. ... inform therapeutic decision-making in oncology, today announced that it ... 2014 to discuss the Company's financial results for the ... update about the business in the current fiscal year. ... beginning on Thursday, August 14, 2014, at 5 p.m. ...
(Date:7/31/2014)... Francisco, Calif. (PRWEB) July 31, 2014 ... newly diagnosed patients with an overview of the disease ... management of drug side effects, as well as updates ... “We’re grateful to Dr. Sandy Srinivas for organizing this ... survivor of kidney cancer. “Sandy and her colleagues have ...
Breaking Biology Technology:Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2
... deCODE genetics,(Nasdaq: DCGN ) today announced its ... 2008. A conference call to discuss the,quarter,s results, ... webcast live tomorrow, Friday, November 7, at 8:00am ... third quarter 2008 was $11.3 million, compared,to $22.2 ...
... NGX-4010 for management of pain associated ... with PHN, ... review for NGX-4010 ... NGSX ), a biopharmaceutical company focused on developing and,commercializing novel pain management ...
... While Public Relations has,long been used as a ... ability to reach consumers has never been greater. ... the traditional press,release as effective and low-cost methods ... was conducted by Best Practices, LLC to,identify what ...
Cached Biology Technology:deCODE genetics Announces Third Quarter 2008 Financial Results 2deCODE genetics Announces Third Quarter 2008 Financial Results 3deCODE genetics Announces Third Quarter 2008 Financial Results 4deCODE genetics Announces Third Quarter 2008 Financial Results 5deCODE genetics Announces Third Quarter 2008 Financial Results 6deCODE genetics Announces Third Quarter 2008 Financial Results 7deCODE genetics Announces Third Quarter 2008 Financial Results 8deCODE genetics Announces Third Quarter 2008 Financial Results 9deCODE genetics Announces Third Quarter 2008 Financial Results 10deCODE genetics Announces Third Quarter 2008 Financial Results 11deCODE genetics Announces Third Quarter 2008 Financial Results 12NeurogesX Reports Third Quarter 2008 Results 2NeurogesX Reports Third Quarter 2008 Results 3NeurogesX Reports Third Quarter 2008 Results 4NeurogesX Reports Third Quarter 2008 Results 5NeurogesX Reports Third Quarter 2008 Results 6NeurogesX Reports Third Quarter 2008 Results 7NeurogesX Reports Third Quarter 2008 Results 8NeurogesX Reports Third Quarter 2008 Results 9New Study Shares Best Practices in Biopharma Public Relations 2
(Date:7/31/2014)... , July 31, 2014 AFFiRiS AG ... York results of AFF008, a Phase I clinical ... the first therapy against the protein alpha-synuclein, a promising Parkinson,s ... J. Fox Foundation for Parkinson,s Research (MJFF) supported the study ... press conference on the impact a disease-modifying therapy would have ...
(Date:7/31/2014)... July 31, 2014 For the first time, ... the implantation of the SynCardia temporary Total Artificial Heart ... video posted on the Journal of Visualized Experiments website. ... the paper on the SynCardia Total Artificial Heart implantation ... accompanies "Implantation of the SynCardia Total Artificial Heart," a ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 ... developing better, faster and affordable treatments for tuberculosis (TB), ... Senior Vice President, Market Access. Ms. Robertson joins the ... the company,s business in Sub-Saharan Africa and ... will oversee the TB Alliance,s efforts to ensure beneficial ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3
... Rapid Fire Marketing (Pink Sheets: RFMK ) announced ... Manufacturer to begin the development of the Pocket Puffer and the ... all specifications are met, the manufacturing facility will set up the ... a patent of the new device once complete and approved. ...
...  Ameritox, the national leader in pain medication monitoring, ... against San Diego-based Millennium Laboratories seeking damages, injunctive ... and unfair trade practices.  The Ameritox filing alleges ... in violations of the Lanham Act, unfair competition ...
Cached Medicine Technology:Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler 2Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages 2Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages 3